cnbc.com / .cnbc-com-health-care / Page 4

The health care sector has been the big loser in the market since the election.

This week the company completed the return of Quarter Pounder burgers, with slivered onions, to all restaurant menus nationwide.

Robert F. Kennedy Jr. has been a vocal critic of obesity drugs belonging to the fast-growing GLP-1 class.

Donald Trump had said that if elected president he would have Robert F. Kennedy Jr. "go wild on health." HHS oversees Medicare, Medicaid, CDC and FDA.

Tariffs? More M&A? Jim Cramer explains what Donald Trump's return to the White House could mean for the Investing Club portfolio.

Amazon announced Prime members can access new upfront pricing to treat five common conditions like erectile disfunction and men's hair loss.

Oura CEO Tom Hale spoke to CNBC about the smart ring product category and the impact of Samsung's entrance into the space.

The lawsuit, filed Tuesday in U.S. District Court in Delaware, is the latest in a series of patent challenges against Medtronic.

AstraZeneca said it is doubling down on its investment in its U.S. business. Meanwhile, General Catalyst has agreed to purchase Summa Health for $485 million.

Analysts cited data from a phase one study showing the highest dose of Amgen's MariTide was linked to roughly 4% loss of bone mineral density over 12 weeks.